Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunogenicity and Safety of Two Doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Liquid Vaccine (GSK 357941A) in Healthy Infants.
Brief Summary: This study will provide data on the immune response and safety of GSK Biologicals' HRV liquid vaccine when given along with the routine infant immunizations in Philippines.


Options:
A: Arm Label: Primary 1: Rotavirus vaccine 6 and 10 weeks; Type: ACTIVE_COMPARATOR; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 1: Rotavirus vaccine 6, 10 and 14 weeks; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 1: Rotavirus vaccine 10 and 14 weeks; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 2: Rotavirus vaccine withholding breast feeding; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Primary 2: Rotavirus vaccine with immediate breast feeding; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine | Arm Label: Baseline seroconversion for rotavirus; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Rotavirus vaccine; Assigned to Arm(s): Primary 1: Rotavirus vaccine 10 and 14 weeks, Primary 1: Rotavirus vaccine 6 and 10 weeks, Primary 1: Rotavirus vaccine 6, 10 and 14 weeks, Primary 2: Rotavirus vaccine with immediate breast feeding, Primary 2: Rotavirus vaccine withholding breast feeding
B: Arm Label: Study Group 1: DAPTACEL®, ActHIB®, and IPOL®; Type: EXPERIMENTAL; Interventions: Biological: DAPTACEL®. (DTaP), IPOL®., and ActHIB®. | Arm Label: Study Group 2: Pentacel®; Type: EXPERIMENTAL; Interventions: Biological: Pentacel®: DTaP-IPV/Hib combined | Arm Label: Study Group 3: DTaP-IPV and ActHIB®; Type: EXPERIMENTAL; Interventions: Biological: DTaP-IPV and ActHIB® | Arm Label: Study Group 4: Pentacel®; Type: EXPERIMENTAL; Interventions: Biological: Pentacel®: DTaP-IPV/Hib combined | Intervention Type: BIOLOGICAL; Name: DAPTACEL®. (DTaP), IPOL®., and ActHIB®.; Assigned to Arm(s): Study Group 1: DAPTACEL®, ActHIB®, and IPOL® | Intervention Type: BIOLOGICAL; Name: Pentacel®: DTaP-IPV/Hib combined; Assigned to Arm(s): Study Group 2: Pentacel® | Intervention Type: BIOLOGICAL; Name: DTaP-IPV and ActHIB®; Assigned to Arm(s): Study Group 3: DTaP-IPV and ActHIB® | Intervention Type: BIOLOGICAL; Name: Pentacel®: DTaP-IPV/Hib combined; Assigned to Arm(s): Study Group 4: Pentacel®
C: Arm Label: PLACEBO-ROTARIX-ROTARIX GROUP; Type: EXPERIMENTAL; Interventions: Biological: Rotarix™, Biological: Placebo | Arm Label: ROTARIX-PLACEBO-ROTARIX GROUP; Type: EXPERIMENTAL; Interventions: Biological: Rotarix™, Biological: Placebo | Arm Label: PLACEBO GROUP; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Rotarix™; Assigned to Arm(s): PLACEBO-ROTARIX-ROTARIX GROUP, ROTARIX-PLACEBO-ROTARIX GROUP | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): PLACEBO GROUP, PLACEBO-ROTARIX-ROTARIX GROUP, ROTARIX-PLACEBO-ROTARIX GROUP
D: Intervention Type: BIOLOGICAL; Name: Human rotavirus liquid vaccine; Assigned to Arm(s): N/A

Answer: C